This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bioceuticals Arzneimittel Ag. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Michael Mack - Innovator in Erythropoietin Purification
Introduction
Michael Mack is a notable inventor based in Bad Vilbel, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of erythropoietin. His innovative methods have the potential to enhance the quality and efficacy of this important therapeutic protein.
Latest Patents
Michael Mack holds a patent for a "Method for purifying erythropoietin." This invention relates to a method for producing recombined erythropoietin with a particularly high degree of purity (≥98%). The method consists of at least five chromatographic purification steps, including at least two anion exchange chromatographs, one hydrophobic interaction chromatography, one affinity chromatography, and one hydroxyapatite chromatography. In preferred embodiments, the method does not require any exclusion chromatography or reversed-phase chromatography. The specific order of the chromatographic purification steps includes: i) a first anion exchange chromatography, ii) an affinity chromatography, preferably a dye affinity chromatography, iii) a hydrophobic interaction chromatography, iv) a hydroxyapatite chromatography, and v) a second anion exchange chromatography.
Career Highlights
Michael Mack is associated with Bioceuticals Arzneimittel AG, where he applies his expertise in biopharmaceutical development. His work focuses on improving the production processes of critical therapeutic proteins, which are essential for treating various medical conditions.
Collaborations
Michael collaborates with talented professionals in his field, including Christof Schumann and Jan-Ole Hesse. Their combined efforts contribute to advancing the science of biopharmaceuticals and enhancing the quality of medical treatments.
Conclusion
Michael Mack's innovative approach to erythropoietin purification exemplifies the importance of advancements in biopharmaceuticals. His contributions are vital for improving therapeutic outcomes and ensuring high-quality medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile